(1 - 15 von 19
)
Merck Serono: Ready-to-Use Formulation of Recombinant Growth Hormone...
www.finanznachrichten.de
... adherent with their treatment regimen," said Professor Pierre Chatelain, of Hôpital Mère-Enfant (Claude Bernard University, Lyon, France).
sortiert nach Relevanz / Datum